You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Bortezomib monotherapy for relapsed multiple myeloma

  • Technology appraisal guidance
  • Reference number: TA129
  • Published:  23 October 2007
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Consultee and commentator comments on the ACD

  • Department of Health

  • Department of Health, Social Services and Public Safety - Northern Ireland

  • Leukaemia care

  • Leukemia Research, International Myeloma Foundation (UK) and Leukaemia Care

  • Leukemia Research, International Myeloma Foundation (UK), Leukaemia Care and Cancerbackup

  • Royal College of Pathologists

  • Royal College of Radiologists

  • UK Myeloma Forum

  • Welsh Assembly Government

  • Ortho Biotech


This page was last updated: 30 March 2010

Back to top